About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04830488

Body Image After Head and Neck Cancer Treatment

This is a pilot study of the Body Image after Head and Neck Cancer Treatment Program \[BIHNC\]. It is a six-week, psychoeducational, web-based program that includes e-learning didactic modules and per...

Lead sponsor: Bethany Rhoten•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Bethany Rhoten

Specific Aim 1: To assess the feasibility and acceptability of \[BIHNC\] in patients who have completed treatment for head and neck cancer and who have body image concerns. H1a: Eighty percent of enrolled study participants who complete baseline self-report measures will complete the BIHNC Program. H1b: Eighty percent of study participants completing the BIHNC Program will rate it acceptable on the intervention evaluation form. Specific Aim 2: To assess the preliminary efficacy of BIHNC for reducing body image concerns in patients who have completed treatment for head and neck cancer and who have body image concerns. H2: Body image scores will improve from pre- to post- intervention

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Completion of any form of head and neck cancer treatment between 3 and 24 months previously at study enrollment
•Answer in the affirmative to at least one of two questions concerning dissatisfaction with the way their body looks or function
•Have clinically significant body image concerns as defined by (BIS score \> 10)

Exclusion Criteria

•Undergoing head and neck cancer treatment at time of study enrollment
•Cognitive impairment that would preclude ability to provide informed consent
•Unable to read text on a computer screen
•Not able to read and understand English

Related studies

RECRUITINGPhase 1

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

NCT05076760 · Solid Tumor, Advanced Cancer, and more

RECRUITINGPhase 2/3

Trop2-targeted immunoPET Imaging of Solid Tumors

NCT06851663 · Solid Tumor, Solid Carcinoma, and more

DESTINY-PANTUMOUR04

NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more

RECRUITINGPhase 2

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

NCT07209189 · Head and Neck Cancer, Squamous Cell Carcinoma, and more

RECRUITINGPhase 2

Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

NCT06477692 · Head and Neck Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 9, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment7

Start dateApr 2021

Last updatedAug 9, 2024

Condition

Head and Neck Cancer

Locations shown

Vanderbilt University Medical Center

Nashville, Tennessee

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 9, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions